145 related articles for article (PubMed ID: 21122582)
21. How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
Shah A; Pakneeshan S; Jones MP; Koloski N; Callaghan G; Morrison M; Holtmann G
Indian J Gastroenterol; 2022 Oct; 41(5):519-524. PubMed ID: 36217097
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
Fratila OC; Craciun C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
[TBL] [Abstract][Full Text] [Related]
24. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
25. [Colorectal cancer in ulcerative colitis].
Laugesen KB; Tøttrup A
Ugeskr Laeger; 2014 Jan; 176(4A):V07130441. PubMed ID: 25347248
[TBL] [Abstract][Full Text] [Related]
26. [Ulcerative colitis--difficulties of differential diagnosis in children].
Alieva ÉI; Potapova EA
Eksp Klin Gastroenterol; 2014; (1):102-6. PubMed ID: 25518464
[TBL] [Abstract][Full Text] [Related]
27. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
28. Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature.
Khosa K; Clarke K
Int J Colorectal Dis; 2014 Nov; 29(11):1313-20. PubMed ID: 24990353
[TBL] [Abstract][Full Text] [Related]
29. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
[TBL] [Abstract][Full Text] [Related]
30. Rectal malignant lymphoma complicating ulcerative colitis treated with long-term cyclosporine A.
Shibahara T; Miyazaki K; Sato D; Matsui H; Yanaka A; Nakahara A; Tanaka N
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):336-8. PubMed ID: 16460502
[No Abstract] [Full Text] [Related]
31. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
[TBL] [Abstract][Full Text] [Related]
32. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
33. Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.
Horai Y; Satoru O; Lapalme-Remis S; Sumiyoshi R; Nakashima Y; Suzuki T; Okada A; Kawashiri SY; Ichinose K; Tamai M; Yamasaki S; Nakamura H; Takeshima F; Origuchi T; Kawakami A
Mod Rheumatol; 2013 May; 23(3):572-6. PubMed ID: 22718488
[TBL] [Abstract][Full Text] [Related]
34. [CLINICAL CASE OF COMBINATION OF PRIMARY SCLEROSING CHOLANGITIS WITH NONSPECIFIC ULCERATIVE COLITIS IN TWINS MONOZYGOTIC].
Gubergrits NB; Belyayeva NV; Klochkov AY; Fomenko PG; Lukashevich GM
Eksp Klin Gastroenterol; 2015; (11):87-91. PubMed ID: 27214994
[TBL] [Abstract][Full Text] [Related]
35. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
36. Anti-TNF-A therapy about infliximab and adalimamab for the effectiveness in ulcerative colitis compared with conventional therapy: a meta-analysis.
Zhou Z; Dai C; Liu WX
Hepatogastroenterology; 2015; 62(138):309-18. PubMed ID: 25916055
[TBL] [Abstract][Full Text] [Related]
37. Linear IgA Bullous Dermatosis Preceding the Diagnosis of Primary Sclerosing Cholangitis and Ulcerative Colitis: A Case Report.
Humphrey VS; Lee JJ; Supakorndej T; Malik SM; Huen AC; Jaroslaw J
Am J Dermatopathol; 2019 Jul; 41(7):498-501. PubMed ID: 30461424
[TBL] [Abstract][Full Text] [Related]
38. Rare location of primary non-Hodgkin's lymphoma in the rectum.
Shakya VC; Agrawal CS; Sah P; Pradhan A; Adhikary S
JNMA J Nepal Med Assoc; 2013; 52(191):508-11. PubMed ID: 24907961
[TBL] [Abstract][Full Text] [Related]
39. Infliximab for refractory ulcerative colitis.
Chey WY; Hussain A; Ryan C; Potter GD; Shah A
Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
[TBL] [Abstract][Full Text] [Related]
40. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.
de Chambrun GP; Nachury M; Funakoshi N; Gerard R; Bismuth M; Valats JC; Panaro F; Navarro F; Desreumaux P; Pariente B; Blanc P
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1247-1252. PubMed ID: 30052539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
